|
|
| Volume 17 • Issue 17 |
September 20, 2017 |
 |
|
|
 |
| |
 |
|
|
LOOK-ALIKE/SOUND-ALIKE ALERT: TROSEC®, LOSEC® AND PROZAC®
Sunovion Pharmaceuticals Canada Inc. would like to alert health care professionals that prescriptions for PrTROSEC® (trospium chloride), a drug approved in Canada on January 10, 2006 for the treatment of overactive bladder, could potentially be confused with those for PrLOSEC® and/or PrPROZAC®.
Read more
|
|
|
|
| |
 |
|
|
We are pleased to invite you to attend the 2017 Thrombosis Canada CCCEP accredited education conference, Thrombosis Pearls and Perils, 2017.
Read more
|
|
|
|
 |
| |
 |
|
|
|
REIMBURSEMENT UPDATE:
Paladin Labs is pleased to announce that Metadol-D® 10mg/mL 1L is now reimbursed in ON, QC, AB, MB, NIHB and NB! Read more
|
|
 |
| |
 |
|
|
Do you see candidates for Humalog® 200 units/mL KwikPen® in your pharmacy?
Read more
|
|
|
|
| |
 |
|
|
PREVENTION AND TREATMENT OF IRON DEFICIENCY
Read more
|
|
 |
| |
 |
|
|
NEW GOLD BOND ULTIMATE ECZEMA RELIEF LOTION
2% Colloidal Oatmeal. Clinically proven to help relieve 5 eczema symptoms.
Read more
|
|
|
|
